Indeed, among the broader KRAS mutational landscape, KRAS G12A has been known to occur at low frequencies in CRC, comprising approximately 3–7% [5,6,7,10], in line with our observation: 3.0% in the FMU cohort and 3.4% in the AC-ICAM cohort. Here, KRAS is linked to colorectal carcinoma.